Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer

Cancer

Volumn 119, Issue 18, 2013, Pages 3367-3376

  Tung, Min Che ^a,c   Wu, Heng Hsiung ^b   Cheng, Ya Wen ^c   Wang, Lee ^d   Chen, Chih Yi ^e   Yeh, Sauh Der ^c   Wu, Tzu Chin ^f   Lee, Huei ^c  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

8 dihydro 2 38; prime; deoxyguanosine; 8 oxo 7; epidermal growth factor receptor; human papillomavirus; lung cancer; mutation

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE; PROTEIN E6;

ARTICLE; CONTROLLED STUDY; EGFR GENE; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPF GENE; TAIWAN;

8-DIHYDRO-2& PRIME;-DEOXYGUANOSINE; 8-OXO-7; EPIDERMAL GROWTH FACTOR RECEPTOR; HUMAN PAPILLOMAVIRUS; LUNG CANCER; MUTATION;

CARCINOMA, NON-SMALL-CELL LUNG; DEOXYGUANOSINE; DNA-BINDING PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MUTAGENESIS; MUTATION; ONCOGENE PROTEINS, VIRAL; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRESSOR PROTEINS; TRANSFECTION;

EID: 84883600818     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28220     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108. (Pubitemid 40372904)
2. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE,. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst. 2006; 98: 691-699. (Pubitemid 43832505)
3. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 2005; 97: 339-346. (Pubitemid 40425952)
4. Tomizawa Y, Iijima H, Sunaga N, et al. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Clin Cancer Res. 2005; 11: 6816-6822. (Pubitemid 41428736)
5. Sun S, Schiller JH, Gazdar AF,. Lung cancer in never smokers-a different disease. Nat Rev Cancer. 2007; 7: 778-790. (Pubitemid 47463669)
6. Rudin CM, Avila-Tang E, Harris CC, et al. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res. 2009; 15: 5646-5661.
7. Linardou H, Dahabreh IJ, Bafaloukos D, Kosmidis P, Murray S,. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. Nat Rev Clin Oncol. 2009; 6: 352-366.
8. D'Angelo SP, Pietanza MC, Johnson ML, et al. Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas. J Clin Oncol. 2011; 29: 2066-2070.
9. Lee YJ, Cho BC, Jee SH, et al. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol. 2010; 28: 487-492.
10. Taguchi A, Politi K, Pitteri SJ, et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell. 2011; 20: 289-299.
11. Kawahara A, Azuma K, Hattori S, et al. The close correlation between 8-hydroxy-2′-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer. Hum Pathol. 2010; 41: 951-959.
12. Romano G, Sgambato A, Mancini R, et al. 8-Hydroxy-2′-deoxyguanosine in cervical cells: correlation with grade of dysplasia and human papillomavirus infection. Carcinogenesis. 2000; 21: 1143-1147. (Pubitemid 30389339)
13. Cheng YW, Chiou HL, Sheu GT, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001; 61: 2799-2803.
14. Cheng YW, Wu MF, Wang J, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res. 2007; 67: 10686-10693. (Pubitemid 350145894)
15. Kato T, Koriyama C, Khan N, et al. EGFR mutations and human papillomavirus in lung cancer. Lung Cancer. 2012; 78: 144-147.
16. Chang JT,. An economic and efficient method of RNAi vector constructions. Anal Biochem. 2004; 334: 199-200. (Pubitemid 39304092)
17. Wu HH, Cheng YW, Chang JT, Wu TC, Liu WS, Chen CY, et al. Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappaB activation. Oncogene. 2010; 29: 4330-4340.
18. Chiang HC, Tsou TC,. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells. Toxicol In Vitro. 2009; 23: 897-905.
19. Lin SY, Tsai SJ, Wang LH, Wu MF, Lee H,. Protection by quercetin against cooking oil fumes-induced DNA damage in human lung adenocarcinoma CL-3 cells: role of COX-2. Nutr Cancer. 2002; 44: 95-101. (Pubitemid 36359326)
20. Chao MR, Yen CC, Hu CW,. Prevention of artifactual oxidation in determination of cellular 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction. Free Radic Biol Med. 2008; 44: 464-473.
21. Wei L, Gravitt PE, Song H, Maldonado AM, Ozbun MA,. Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells. Cancer Res. 2009; 69: 4878-4884.
22. Wingo SN, Gallardo TD, Akbay EA, et al. Somatic LKB1 mutations promote cervical cancer progression [serial online]. PLoS One. 2009; 4: e5137.
23. Chung CH, Gillison ML,. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009; 15: 6758-6762.
24. Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333: 1157-1160.
25. Catasus L, Gallardo A, Cuatrecasas M, Prat J,. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters. Mod Pathol. 2008; 21: 131-139. (Pubitemid 351172164)
26. Russo MT, De Luca G, Casorelli I, et al. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis. Cancer Res. 2009; 69: 4372-4379.
27. Xinarianos G, Liloglou T, Prime W, et al. P53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma. Int J Cancer. 2002; 101: 248-252. (Pubitemid 34970892)
28. Warnick CT, Dabbas B, Ford CD, Strait KA,. Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells. J Biol Chem. 2001; 276: 27363-27370.
29. Scherer SJ, Maier SM, Seifert M, et al. P53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem. 2000; 275: 37469-37473. (Pubitemid 32004853)
30. Chang JW, Chen YC, Chen CY, Chen JT, Chen SK, Wang YC,. Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer. Clin Cancer Res. 2000; 6: 1639-1646.
31. Cheng YW, Wu TC, Chen CY, Chou MC, Ko JL, Lee H,. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus 16/18-infected lung tumorigenesis. Clin Cancer Res. 2008; 14: 7173-7179.
32. Wu HH, Wu JY, Cheng YW, et al. cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidyl-inositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer. Clin Cancer Res. 2010; 16: 5200-5210.
33. WAF1/CIP1 via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early stage human papillomavirus-associated lung cancer. Clin Cancer Res. 2011; 17: 1895-1905.